TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT07076680

A Real-World Study in Patients With HR+/HER2- Advanced Breast Cancer

Cause of deathFunding or business, also slow enrollment Automatic label, confidence 0.5, unverified. How labels are made.
“Due to a strategic decision by the company, the study will not proceed, and no subjects have been enrolled to date.”

The sponsor’s own words in the registry.

Life of this trial

202520262027Registered2025-06-17Planned start2025-08-01 (planned)Withdrawn (as of)2025-11-28

Vital statistics

Status
Withdrawn
Sponsor
SciClone Pharmaceuticals
Sponsor type
Industry
Conditions
Breast Cancer Metastatic; HR+/HER2- Advanced Breast Cancer
Participants
0
Sites
1
Countries
China

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.